Review: could Xeloda cause Interstitial lung disease?
Summary: Interstitial lung disease is found among people who take Xeloda, especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months, also take medication Tykerb, and have Breast cancer.
We study 18,062 people who have side effects while taking Xeloda from FDA and social media. Among them, 186 have Interstitial lung disease. Find out below who they are, when they have Interstitial lung disease and more.
You are not alone: join a support group for people who take Xeloda and have Interstitial lung disease >>>
Xeloda has active ingredients of capecitabine. It is often used in breast cancer metastatic. (latest outcomes from 18,176 Xeloda users)
Interstitial lung disease
Interstitial lung disease has been reported by people with rheumatoid arthritis, high blood pressure, lung cancer - non-small cell, osteoporosis, prostate cancer. (latest reports from 20,667 Interstitial lung disease patients)
On Apr, 9, 2015: 18,062 people reported to have side effects when taking Xeloda. Among them, 186 people (1.03%) have Interstitial Lung Disease.
Time on Xeloda when people have Interstitial lung disease * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Interstitial lung disease||37.27%||41.82%||16.36%||2.73%||1.82%||0.00%||0.00% |
Age of people who have Interstitial lung disease when taking Xeloda * :
|Interstitial lung disease||0.00%||0.00%||0.00%||3.70%||1.06%||7.94%||28.04%||59.26% |
Severity of Interstitial lung disease when taking Xeloda ** :
How people recovered from Interstitial lung disease ** :
Top conditions involved for these people * :
- Breast cancer (73 people, 39.25%)
- Breast cancer metastatic (37 people, 19.89%)
- Hypertension (22 people, 11.83%)
- Rectal cancer metastatic (19 people, 10.22%)
- Prophylaxis (18 people, 9.68%)
Top co-used drugs for these people * :
- Tykerb (58 people, 31.18%)
- Herceptin (45 people, 24.19%)
- Oxaliplatin (45 people, 24.19%)
- Zometa (40 people, 21.51%)
- Oxycontin (36 people, 19.35%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Get connected: join our support group of xeloda and interstitial lung disease on
Do you have Interstitial Lung Disease while taking Xeloda?
You are not alone! Join a support group on :
- support group for people who take Xeloda and have Interstitial Lung Disease
- support group for people who take Xeloda
- support group for people who have Interstitial Lung Disease
Drugs in real world that are associated with:
Could your condition cause:
Recent Xeloda related drug comparison:
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.